New findings in ocular histoplasmosis.
The ocular histoplasmosis syndrome consists of punched-out, atrophic chorioretinal lesions, and peripapillary scarring in the absence of vitreal inflammation. Choroidal neovascularization is the cause of significant visual loss in involved eyes and is estimated to occur in up to 5% of affected eyes. An experimental primate model has given us a better understanding of the possible etiology and pathogenesis. Laser therapy for extrafoveal and juxtafoveal choroidal neovascularization has been shown to be effective. Recent advances in surgical technique and instrumentation have demonstrated the potential for the successful treatment of subfoveal choroidal neovascularization. The surgical specimens obtained from this approach have allowed for the study of the active process of neovascularization in this disease. This report summarizes our current knowledge regarding the pathogenesis and epidemiology of ocular histoplasmosis and the treatments currently utilized in the management of its associated choroidal neovascularization.
Callanan
D
D
Jost
B F
BF
D000818:Animals; D001284:Atrophy; D002829:Choroid / Q000098:blood supply / Q000473:pathology; D015862:Choroid Diseases / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D015821:Eye Infections, Fungal / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D005584:Fovea Centralis; D006660:Histoplasmosis / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D006801:Humans; D017075:Laser Coagulation; D008251:Macaca; D009389:Neovascularization, Pathologic / Q000382:microbiology / Q000601:surgery; D012160:Retina / Q000473:pathology; D012164:Retinal Diseases / Q000382:microbiology* / Q000473:pathology / Q000601:surgery